Summit Therapeutics trades 4,881 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
Summit Therapeutics trades 2,841 contracts. The company has the following event: Clinical Trial Collaboration to Evaluate Ivonescimab in Combination with GSK's B7-H3 Antibody Drug Conjugate on Jun 15, 2026.
Summit Therapeutics has traded lower yet again today, last trading at 16.00. Since this spiral started on 12-Nov-2025, the stock has dropped -16.5% in total. This is the longest downward trend in the last year for SMMT. View Stock Chart
